Mejores acciones de salud — El consenso
¿Qué acciones de salud y biotecnología recomiendan los YouTubers de finanzas con análisis real? Esta lista ordena el consenso del sector.
ITIntegrys23“The YouTuber recommends Integrys for its supply of ultra-pure chemicals and materials essential for advanced c…”
ADADPT20“The YouTuber identifies Adaptive Biotech Technologies (ADPT) as a potential 10x stock by 2030, based on a patt…”
HIHims & Hers18“The YouTuber argues that Hims is significantly undervalued, trading at 13 times free cash flow while growing r…”
TX10X Genomics17“The YouTuber is highly excited about 10X Genomics, a leader in spatial biology that allows scientists to under…”
CMCompass Pathways16“The YouTuber suggests buying Compass Pathways as a calculated speculation due to its potential for significant…”
ABAbbott Laboratories15“The YouTuber suggests Abbott Laboratories as a potential long-term dividend stock. They note its fair financia…”
ATATAI Life Sciences8“The YouTuber recommends ATAI Life Sciences as a 'diversified play' in the psychedelic therapy market. Unlike C…”
GHGH Research7“The YouTuber suggests GH Research as a 'technology bet' in the psychedelic therapy sector, focusing on a compo…”
“The analyst sees tremendous upside potential in Owlet, despite its high-risk profile and recent CEO change. He…”
ISIntuitive Surgical2“The YouTuber suggests reconsidering Intuitive Surgical, highlighting its strong moat primarily from high switc…”
TOTopicus1“The YouTuber highly recommends Topicus, citing its high growth rates, shareholder-friendly approach (no stock-…”
NVNovo Nordisk1“The YouTuber argues Novo Nordisk is historically cheap despite recent negative sentiment due to lowered guidan…”
“The YouTuber argues that Novo Nordisk is significantly undervalued, trading at half the market's price-to-five…”
BSBoston Scientific0“The YouTuber identifies Boston Scientific as a pure Tier 1 robotics company, building physical systems for med…”
ALAlign Technologies0“The YouTuber suggests Align Technologies is a buy due to its current undervaluation, trading at a P/E of aroun…”
CHChemed0“The YouTuber recommends Chemed as a buy, noting its current P/E of 20 is significantly below its historical av…”
SASanofi0“The YouTuber believes Sanofi is a good buying opportunity due to its current undervaluation, evidenced by a lo…”
PFPfizer0“The YouTuber suggests Pfizer is a buy due to its current low valuation (P/E of 12.99, P/B of 1.57) after a sig…”
CNCentene0“The YouTuber identifies Centene as the cheapest stock in the healthcare insurance sector based on his 'value r…”
SMSara Medtec Ter SMTI0“Adriconomics is buying SMTI, a micro-cap healthcare company focused on wound care, because his custom 'value r…”
ELElevance0“The YouTuber states that Elevance is 'extremely cheap' with a value ratio under 10, suggesting it is a good in…”
CLColoplast0“The analyst suggests Coloplast is an interesting value due to its significant price drop, currently trading 40…”
EXExelixis0“The YouTuber intends to build a small position in Exelixis due to its strong position in the oncology market, …”
DXDexcom0“The analyst views Dexcom as a potential bargain after a significant stock drop due to a lowered outlook, which…”
LNLanthus Holdings INC0“The YouTuber suggests Lanthus Holdings is an interesting and potentially cheap stock, trading at a price to fr…”
POInsulet0“The YouTuber sees Insulet as a good entry opportunity despite recent pressure from weight-loss drugs, arguing …”
JNJohnson and Johnson0“The YouTuber highlights Johnson & Johnson as a strong performer within the healthcare sector during past marke…”
WBWalgreens0“The YouTuber advises investors to continue avoiding Walgreens, labeling it a 'value trap.' He argues that Amaz…”
IQIQVIA0“The YouTuber suggests IQVIA, trading 42.5% below its recent high, as a buy. The company is a market leader in …”
VHVanguard Healthcare ETF0“The YouTuber recommends the Vanguard Healthcare ETF (VHT) for diversification within the healthcare sector. Th…”
XLHealthcare Select Sector SPDR fund0“The YouTuber suggests the Healthcare Select Sector SPDR fund (XLV) as a defensive investment, arguing that peo…”
HCHCA Healthcare0“The YouTuber sees a good opportunity to buy HCA Healthcare, a leading US healthcare provider, due to its stron…”
ABAbbVie0“The YouTuber recommends AbbVie, a global biopharmaceutical company, due to its focus on innovative therapies l…”
VKViking Therapeutics0“The YouTuber is buying Viking Therapeutics, a biopharmaceutical company with promising GLP-1 drugs in trials f…”
SMSummit Therapeutics0“The YouTuber sees Summit Therapeutics as a speculative buy due to its promising cancer drug for non-small cell…”
OWOwlette0“The YouTuber is holding Owlet, a small-cap company with significant share appreciation. He highlights its baby…”
IDIDEX Laboratories0“The YouTuber purchased IDEX Laboratories, a device manufacturer for animal health (livestock and pets). He not…”
DODocimity0“The YouTuber finds Docimity, a niche messaging app for doctors, 'interesting' due to its impressive functional…”
CVCVS0“The YouTuber owns a small piece of CVS, having initially liked its merger with Aetna. He believes they haven't…”
BMBiomerica Inc.0“The YouTuber identifies Biomerica as a potential 'hidden gem' in advanced diagnostics for gastrointestinal dis…”
Aún no hay datos — el rastreador está en marcha.
Por qué puedes confiar en el ranking
Sin hype ni selección interesada — solo análisis cualificados, ponderados por igual entre todos los creadores que seguimos.Solo análisis cualificados
Una acción nombrada, una postura clara de compra o venta y un razonamiento real. Las menciones de pasada y el hype se filtran.
Un voto por creador
Cada canal cuenta una vez por acción, así una sola voz fuerte no puede distorsionar el ranking.
Consenso ponderado
Ponderamos cuántos creadores coinciden, cuánta convicción tienen y cómo de reciente es cada análisis.
Preguntas frecuentes
¿Cómo se calcula el ranking?
Rastreamos a YouTubers de finanzas, transcribimos sus vídeos y usamos IA para extraer solo análisis cualificados (acción nombrada + dirección clara + razonamiento real). Cada canal cuenta una vez por acción; el ranking pondera consenso, calidad, convicción y actualidad.
¿Qué cuenta como señal cualificada?
Una acción nombrada, una postura clara de compra o venta y un razonamiento real — valoración, fundamentales, un catalizador o un patrón técnico. Las menciones de pasada sin argumento se ignoran.
¿Con qué frecuencia se actualizan los datos?
Rastreamos a diario a los YouTubers de finanzas, transcribimos los vídeos nuevos y recalculamos el ranking cada día — así suben los análisis más recientes y de mayor convicción.
¿YouTuberStocks es gratis?
Sí — es totalmente gratis y cada señal enlaza al vídeo original como fuente.
¿Esto es asesoramiento financiero?
Esto no es asesoramiento financiero. Este sitio reúne opiniones de terceros (YouTubers de finanzas) con fines informativos. No tomes decisiones de inversión basándote solo en esto.